Cushing’s syndrome is a disorder that occurs when your body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps your body respond to stress.
Numerous studies have suggested that hypercortisolism is present in 3-8 percent of unselected patients with type 2 diabetes mellitus. Recent data from the Catalyst study suggest that hypercortisolism may be seen in as many as one-quarter of patients with uncontrolled type 2 diabetes…
The Evolution of our Understanding of the Nuances of Pathologic Cortisol Secretion. A few highlights: Cushing syndrome refers to the classical appearance of hypercortisolism as described by Dr. Harvey Cushing. Many patients with hypercortisolism or
From the desk of PWN cofounder Lewis S. Blevins Jr. M.D. – I’ve always been fascinated with the history of medicine. It’s one of the things that led me to this profession in the first
A new TV ad links cortisol imbalance to Type 2 diabetes—raising awareness of overlooked endocrine factors.
The latest news from Corcept Therapeutics on their Phase 3 GRACE clinical trial clinical trial is excellent. The drug relacorilant significantly reduced high blood pressure and blood sugar levels in people with endogenous Cushing’s syndrome.
On today’s podcast and Cushing’s awareness day and month, we bring you a few excerpts from our soon-to-be-released new book on Cushing’s. The book’s author and Pituitary World News cofounder, Dr. Lewis Blevins, reads from a few selected chapters to give insight into the book’s content.
From the desk of Jorge D. Faccinetti – chief editor and co-founder – I am thrilled to announce that Pituitary World News co-founder Dr. Lewis Blevins has been working on a new book on Cushing’s
From the desk of Dr. Lewis Blevins comes a review of three important studies on Cushing’s Syndrome: Paediatric Cushing syndrome: a prospective, multisite, observational cohort study – The authors of this study report the largest
Our thanks to Corcept Therapeutics for sharing this enlightening panel discussion of the evolution of hypercortisolism moderated by Mike Evans, Senior Director of Commercial Insights at Corcept.
In this brief podcast, Dr. Blevins relates a fascinating Cushings case to talk about the importance of understanding disease patterns and how depth of knowledge gives physicians the critical skills to recognize unusual conditions.